Amputations under PMB Regulations: The Latest CMScript

By HEOR Staff Writer

January 20, 2023

Council for Medical Schemes latest CMScript focusing on amputations under PMB regulations. Amputation, the removal or loss of a body part, can drastically alter a person’s life. It impacts an individual’s mobility, work capabilities, social interactions, and independence. This article explores the causes of amputations, preventative measures, and the journey towards recovery and rehabilitation.

Life After Amputation: Recovery and Rehabilitation

Amputations due to traumatic and crush injuries, severe burns, diabetes mellitus, peripheral artery diseases, severe infections, and cancers must be funded in line with the PMB Regulations. This would include diagnosis, treatment, and care of PMBs irrespective of the member’s option.

Prosthetic limbs replace the function of the lost body part and are recommended based on the type of amputation, the patient’s general health, and the tasks expected to be performed using the prosthesis. However, not all individuals are suitable for a prosthetic limb, particularly those with serious health conditions such as heart failure.

Preventing Amputations

Preventing amputations involves addressing the underlying issues that may necessitate such a procedure. Lifestyle modifications, including a balanced diet, regular exercise, quitting smoking, and maintaining stable blood sugar, blood pressure, and cholesterol levels, are essential. Regular examination of the legs and feet for sores or changes in skin colour or temperature is also crucial.

Reference url

Recent Posts

Rethinking HEOR Market Access Integration: A Call for Early Engagement Before Phase 3

By João L. Carapinha

November 24, 2025

Early HEOR Market Access Integration In this brief interview on ISPOR, Indranil Bagchi asserts that HEOR market access integration must occur earlier in drug development—ideally before Ph...
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Patient-reported outcomes trends show a clear surge in clinical trials from 2008 to 2023, where usage has doubled in interventional studies, while tools like EQ-5D lead as the top generic instrument, with PROMIS seeing e...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset

By João L. Carapinha

November 18, 2025

Health as a Strategic Economic Imperative A country's enduring strength stems not solely from military or industrial resources but from the vitality and productivity of its populace. A recent EFPIA Guest Blog by Michael Oberreiter frames he...